Brown, Lisle/Cummings, Inc. Laboratory Corp Of America Holdings Transaction History

Brown, Lisle/Cummings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 28, 2024	BUY	$203.72 - $248.97 $25,465 - $31,121	125 Added 71.43%	300 $70.6 Million
Q3 2022 Jun 28, 2024	BUY	$204.81 - $262.19 $10,240 - $13,109	50 Added 40.0%	175 $35.8 Million
Q1 2022 Jun 28, 2024	BUY	$259.82 - $298.18 $19,486 - $22,363	75 Added 150.0%	125 $33 Million
Q4 2021 Jun 28, 2024	BUY	$271.6 - $314.21 $13,580 - $15,710	50 New	50 $15.7 Million

126

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $19.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.